I know Cufflinks and DEGseq can do DE gene analysis. Consider the resolution of mRNA sequence, it will be even more interesting to look at the DE at the exon level rather than the gene level. Does anyone know any available software or adapted method for identification of DE exons for mRNA sequencing?
Unconfigured Ad
Collapse
X
-
Can you explain it in more details about making the exon annotation?Originally posted by Xi Wang View PostCertainly, DEGseq can do this job if you give the gene annotation per exon instead of gene. You need write some simple script to split genes into exons, but remember to follow the refflat format.
All those format conversions are a nightmare for a biology person without too much background in computer science like me. But if you can give more detailed insturctions, I can get help from IT person and get it done.
P.S. Affymetrix is providing exon microarrays now, and I think more and more people will be interested in exon analysis intead of gene. A function of exon expression analysis will certainly be an advantage of DEGseq, which will attract more users as well.
Comment
-
-
Ok, let's start from the exon regions you already have, for example,
then you write into the format below:Code:chr1 100 200 - chr1 1000 1200 - chr1 2000 2300 -
A script will do this automatically.Code:Exon_1 Exon_1 chr1 - 100 200 100 200 1 100, 200, Exon_2 Exon_2 chr1 - 1000 1200 1000 1200 1 1000, 1200, Exon_3 Exon_3 chr1 - 2000 2300 2000 2300 1 2000, 2300,
If you don't have the data for every exon, you need extract the information from gene annotation, and be careful of the redundant exon regions.
Thanks for you suggestion. We may add this function of analyzing differentially expressed exons in our package in next update. That will be more direct to get what you want.
Comment
-
-
An easier way would be to pull down the exons from UCSC in bed format and then use BEDTools' intersectBed utility to count the number of reads mapping to the individual exons. You can then do count statistics or calculate RPKM values for individual exons. If you save your alignment in SAM/BAM format BEDTools can convert your alignments to bed format, otherwise you will have to write your own script or use another utility to convert your aligned reads to bed format.
I think that you might find it difficult to identify differentially spliced exons this way, because you would find so many differentially expressed exons between samples that reflect differential expression rather than differential splicing. To really identify differentially expressed isoforms I think you need a more dedicated algorithm to compare the individual exon levels within a gene to other exons within the same gene. The problem here is that different exons are sequenced with variable efficiency and also mapped with different efficiency (some might contain repeat regions and). These problems are also present when comparing expression between two different genes, but I would think the problem increases as the length of the element decreases because it becomes more and more vulnerable to sequencing and mapping artefacts. Comparing expression of the same gene between to samples is another matter as they are subjected to the same biases, but of course the dynamic range of the measurement may decrease.
Btw, DEGseq seems like a really nice and easy to use package, my concerns regarding its use in this way is merely of a general nature and not specific to DEGseq.Last edited by Thomas Doktor; 02-19-2010, 07:53 AM.
Comment
-
-
I totally agree.Originally posted by Thomas Doktor View PostI think that you might find it difficult to identify differentially spliced exons this way, because you would find so many differentially expressed exons between samples that reflect differential expression rather than differential splicing. To really identify differentially expressed isoforms I think you need a more dedicated algorithm to compare the individual exon levels within a gene to other exons within the same gene. The problem here is that different exons are sequenced with variable efficiency and also mapped with different efficiency (some might contain repeat regions and). These problems are also present when comparing expression between two different genes, but I would think the problem increases as the length of the element decreases because it becomes more and more vulnerable to sequencing and mapping artefacts. Comparing expression of the same gene between to samples is another matter as they are subjected to the same biases, but of course the dynamic range of the measurement may decrease.
Comment
-
-
If you have the well-defined exons for these genes, you can simply use some tools, such as BEDtools, to get the number of reads falling in these exonic regions. Than, statistic methods can be applied to identify the differentially expressed exons. Or some existing tools, such as DEGseq, can help you with the statistical inference.Originally posted by jiwu2573 View PostIf I am particularly interested in a few genes, any easy way to compare those exon expressions within these genes?
Comment
-
Latest Articles
Collapse
-
by mylaserKheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
This guide explains everything you need to know about...-
Channel: Articles
Today, 01:13 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
17 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
10 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
||
|
Started by SEQadmin2, 07-07-2026, 11:05 AM
|
0 responses
22 views
0 reactions
|
Last Post
by SEQadmin2
07-07-2026, 11:05 AM
|
||
|
Started by SEQadmin2, 07-02-2026, 11:08 AM
|
0 responses
31 views
0 reactions
|
Last Post
by SEQadmin2
07-02-2026, 11:08 AM
|
Comment